Patents
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
09/2013
09/17/2013US8536211 Process for the preparation of 5-substituted 1-alkyltetrazoles
09/11/2013CN1867551B Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists
09/11/2013CN103288767A Tetrazole proton transfer agent and preparation method of proton exchange membrane of high-temperature fuel cell thereof
09/05/2013US20130231475 Mri contrast agent having gadolinium complex
09/04/2013CN103282354A N-(tetrazol-5-l)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides
09/03/2013US8524914 Method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same
09/03/2013US8523989 Lead-free primary explosive composition
08/2013
08/29/2013US20130225819 Use of azides in synthesis
08/29/2013US20130224873 Method and device for the detection of sulphur containing species
08/27/2013US8519164 Process and intermediate compounds useful in the preparation of statins
08/27/2013US8518715 Bifunctional polyazamacrocyclic chelating agents
08/22/2013US20130217680 Inhibitors of the Renal Outer Medullary Potassium Channel
08/21/2013CN103261168A Neprilysin inhibitors
08/21/2013CN103261164A Neprilysin inhibitors
08/21/2013CN101484410B Terphenyl derivatives for treatment of alzheimer's disease
08/21/2013CN101421258B Sulfonyl-substituted bicyclic compounds as modulators of ppar
08/20/2013US8513436 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
08/20/2013US8513409 Introverted CB[n] compounds
08/20/2013US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
08/15/2013WO2013117582A1 Process for the preparation of n-hydroxy-1-(1-alkyl-1h-tetrazol-5-yl)-1-phenylmethanimine derivatives
08/15/2013US20130210065 Tetrazolium compound for detecting microorganisms, reagent for detecting microorganisms and method for detecting microorganisms
08/15/2013US20130209760 Alkyl sulfonated tetrazole compound, preparing method thereof, and epoxy resin containing the same, and substrate produced therefrom
08/14/2013CN103249715A Substituted carbamoylcycloalkyl acetic acid derivatives as NEP inhibitors
08/14/2013CN103242192A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
08/08/2013WO2013116682A1 Macrocyclic compounds for modulating il-17
08/08/2013US20130203815 Cytokine inhibitors
08/08/2013US20130202536 Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency
08/07/2013EP2623500A1 Mri contrast agent having gadolinium complex
08/07/2013CN103232403A Preparation method of azacyclo
08/01/2013WO2013083859A3 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
07/2013
07/31/2013CN103224495A Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
07/31/2013CN102351804B Method for recovering valsartan racemate
07/25/2013WO2013108800A1 Substituted phenylazole derivative
07/25/2013US20130190505 Hydrothiolation of Unactivated Alkenes
07/25/2013US20130190370 Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor
07/25/2013US20130189287 Enzymatic conjugation of polypeptides
07/24/2013EP2616450A2 Sulfonamide compounds
07/24/2013EP2616449A1 Anthraquinone compounds and their uses
07/24/2013CN103221398A Tetrazine-trans-yclooctene ligation for the rapid construction of radionuclide labeled probes
07/24/2013CN103221397A New compositions and methods for controlling nematode pests
07/23/2013US8492375 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists
07/23/2013CA2534675C Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors
07/18/2013WO2013104705A1 Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides
07/17/2013CN101903362B Tetrazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists
07/16/2013US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
07/10/2013EP2611786A1 New compositions and methods for controlling nematode pests
07/10/2013EP2611785A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides
07/10/2013CN103201260A Drug derivatives
07/10/2013CN103193669A nNOS-Capon uncoupling compound, preparation method and application thereof
07/10/2013CN101679242B Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof
07/04/2013WO2013056250A3 Cxcr4 inhibiting carriers for nucleic acid delivery
07/03/2013EP2608785A2 Lipomacrocycles and uses thereof
07/03/2013CN102036971B 3- or 4-substituted piperidine compounds
07/03/2013CN102026988B 3-substituted propanamine compounds
07/02/2013US8476432 Process for the preparation of HMG-COA reductase inhibitors and intermediates thereof
06/2013
06/26/2013CN103180291A Alkoxyimino derivative and pest control agent
06/26/2013CN101490034B Fungicide hydroximoyl-tetrazole derivatives
06/20/2013WO2013087577A1 N-(1,2,5-oxadiazol-3-yl), n-(1,3,4-oxadiazol-2-yl), n-(tetrazol-5-yl), and n-(triazol-5-yl) aryl carboxylic acid amides and use thereof as herbicides
06/20/2013US20130158263 Intermediates for the preparation of hmg coa reductase inhibitors and processes for the preparation thereof
06/20/2013US20130156851 Lipomacrocycles and uses thereof
06/19/2013CN103159692A Tetrazole-substituted arylamides
06/19/2013CN103159691A Preparing method and application of isothiocyanate compound
06/19/2013CN103159690A Crystallization form of symmetric macrocyclic amine compound
06/19/2013CN103159632A Ionic liquid compound with anion containing double Lewis base functional groups, preparation method thereof and application thereof
06/13/2013WO2013083859A2 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
06/12/2013EP2601180A1 Highly crystalline valsartan
06/12/2013CN103153969A Mri contrast agents comprising gd-complexes
06/12/2013CN103145636A 1,4-diacyl-3,6-diphenyl-1,4-dihydrotetrazine compound as well as preparation method and application thereof
06/12/2013CN102617498B Valsartan preparation method
06/06/2013US20130144067 Process for the preparation of valsartan
06/05/2013EP2599777A1 Process for the preparation of Calcobutrol
06/05/2013CN102552941B Two-nuclear magnetic resonance imaging contrast agent taking 2,5-dimethylpyrazine as connector and preparation method of two-nuclear magnetic resonance imaging contrast agent
06/05/2013CN101962319B Synthetic micromolecule compound capable of conveying bioactive substances and application thereof
06/04/2013US8455657 Process for the preparation of 3-alkylsulfinylbenzoyl derivatives
05/2013
05/30/2013US20130137737 Highly crystalline valsartan
05/30/2013CA2857014A1 Process for the purification of polyaminocarboxylates
05/29/2013EP2595967A2 Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes
05/28/2013CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
05/23/2013WO2013072924A1 An improved process for the preparation of angiotensin ii antagonists and intermediates thereof.
05/23/2013WO2013072491A1 Methods for preparing functional tetraazacycloalkane compounds using a specific cyclic bisaminal compound
05/23/2013CA2855868A1 Methods for preparing functional tetraazacycloalkane compounds using a specific cyclic bisaminal compound
05/22/2013CN103113303A Nitrogen heterocyclic compound used as CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells) receptor antagonist
05/22/2013CN101479250B Tetrazole-substituted arylamides
05/16/2013WO2013069545A1 Complex compound and optical recording medium containing same
05/15/2013EP2592070A2 Tetrazole-substituted arylamides
05/15/2013EP2590953A1 Tetrazole compounds as calcium channel blockers
05/14/2013US8440820 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
05/14/2013US8440008 Preparation of a lead-free primary explosive
05/10/2013WO2013064459A1 Herbicidally active oxime-ether-substituted benzoylamides
05/10/2013WO2013064458A1 Herbicide/safener compositions containing n-(tetrazol-5-yl) aryl carboxylic acid amides and n-(triazol-5-yl) aryl carboxylic acid amides
05/10/2013WO2013064457A1 5-phenyl-substituted n-(tetrazol-5-yl) aryl carboxylic acid amides and n-(triazol-5-yl) aryl carboxylic acid amides, and use thereof as herbicides
05/10/2013CA2854107A1 Herbicide/safener compositions containing n-(tetrazol-5-yl) aryl carboxylic acid amides and n-(triazol-5-yl) aryl carboxylic acid amides
05/10/2013CA2854098A1 5-phenyl-substituted n-(tetrazol-5-yl) aryl carboxylic acid amides and n-(triazol-5-yl) aryl carboxylic acid amides, and use thereof as herbicides
05/10/2013CA2854060A1 Herbicidally active oxime-ether-substituted benzoylamides
05/08/2013EP2589598A1 5-phenyl substituted N-(Tetrazol-5-yl)- and N-(Triazol-5-yl)aryl carboxylic acid amides and use of same as herbicides
05/08/2013EP2589293A1 Herbicide safener compounds containing N-(Tetrazol-5-yl)- and N-(Triazol-5-yl)aryl carboxylic acid amides
05/08/2013CN103086993A Method for crystallizing valsartan
05/08/2013CN101585784B Method for purifying sartan side chain compound
05/07/2013CA2590349C Potentiators of glutamate receptors
05/02/2013US20130109710 Spiro compounds and pharmaceutical use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 97